KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Elanco Animal Health (ELAN) Leases (2018 - 2025)

Elanco Animal Health (ELAN) has disclosed Leases for 8 consecutive years, with $226.0 million as the latest value for Q4 2025.

  • Quarterly Leases rose 85.25% to $226.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $226.0 million through Dec 2025, up 85.25% year-over-year, with the annual reading at $226.0 million for FY2025, 85.25% up from the prior year.
  • Leases hit $226.0 million in Q4 2025 for Elanco Animal Health, up from $122.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $226.0 million in Q4 2025 to a low of $122.0 million in Q4 2024.
  • Historically, Leases has averaged $158.0 million across 5 years, with a median of $141.0 million in 2022.
  • Biggest five-year swings in Leases: dropped 13.9% in 2021 and later soared 85.25% in 2025.
  • Year by year, Leases stood at $161.0 million in 2021, then decreased by 12.42% to $141.0 million in 2022, then decreased by 0.71% to $140.0 million in 2023, then dropped by 12.86% to $122.0 million in 2024, then surged by 85.25% to $226.0 million in 2025.
  • Business Quant data shows Leases for ELAN at $226.0 million in Q4 2025, $122.0 million in Q4 2024, and $140.0 million in Q4 2023.